Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry
NCT01999946Phase 4Completed
- Sponsor
- NYU Langone Health
- Start
- Jun 2014
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone in opioid use disorder (OUD), sponsored by NYU Langone Health. Started Jun 2014; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01999946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01999946.